| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |